CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION
This organization has already been registered
Someone in your organization has already registered and setup an account. would you like to join their team?Profile owner : i**o@d*********n.o*g
Mission Statement
At Damon Runyon Cancer Research Foundation, we raise money for high-risk, high-reward cancer research done by brilliant young scientists who are willing to push boundaries and break rules. In other words, we fund brave and bold. Because only by being brave and bold, by risking failure, are we going to achieve real and lasting success against a foe as complex, resilient and deadly as cancer.
About This Cause
Since our founding in 1946, promising scientists identified and supported by Damon Runyon have gone on to make breakthrough discoveries that have transformed our understanding of cancer and develop new approaches to prevention, diagnosis and treatment of all forms of this disease. Damon Runyon scientists have: • Been front and center in deciphering the genetic drivers of cancer, including identifying the first cancer-causing gene and leadership in the national Human Genome Atlas project to identify the key genetic drivers of a broad range of cancers. • Pioneered the study of the immune system, which has led to the current success of cancer immunotherapies. • Developed many of the technologies used today to study cancer, such as tools to edit the genome (CRISPR Cas9) and study cancer at the single cell level. Additionally, our scientists: • Proved the link between cigarette smoking and cancer • First cured a solid tumor with chemotherapy • First cured a patient with Stage IV melanoma using only immunotherapy • Were directly involved in the development and approval of new targeted therapies such as Herceptin, Erbitux, Yervoy, and Zelboraf. In fact, in an analysis of 13 recently approved cancer drugs, discoveries by Damon Runyon scientists were cited as important in each one • Have founded innovative biotech companies, such as Juno Therapeutics, Syros Pharmacueticals, Sunesis Pharmaceuticals, and others Damon Runyon has invested nearly $420 million in more than 3,900 exceptional scientists. Damon Runyon cancer researchers have made extraordinary breakthroughs in every area of cancer prevention, diagnosis and treatment. To this day, we support the next generation of leaders: emerging talent with unique insights, drive, and boundless vision. We will not stop until we have the tools to prevent or cure all cancers.